EDF Health

Up from the depths of deception: The chemical industry’s “astroturf” group loses a member, the Ocean Futures Society

By / Published: March 23, 2010

Richard Denison, Ph.D., is a Senior Scientist.

Remember all of my earlier posts about the industry front group, the Coalition for Chemical Safety?  My major complaint was, not that the chemical industry was organizing itself or even seeking support from others, but rather that it was doing so through deception:  Pretending to be something it was not.  Never revealing who is behind the coalition, who’s paying the bills.  Never revealing it was put together by one of the nation’s premier “astroturf” PR firms.  And most importantly, not coming clean about its real identity to the businesses and organizations it approaches to sign up.

Well, the Ocean Futures Society, an ocean protection group founded and led by Jean-Michel Cousteau, has just identified itself as one of the duped groups taken in by the Coalition for Chemical Safety (CCS).  Read More »

Posted in Health policy, Industry influence / Tagged , , | Read 4 Responses

The Katrina chronicles: Formaldehyde-laced trailers set to claim another set of victims

By / Published: March 14, 2010

Richard Denison, Ph.D., is a Senior Scientist.

The Washington Post ran a front-page article Saturday, written by Spencer Hsu, which reported the auction sale by FEMA of most of the 120,000 notorious formaldehyde-tainted trailers it had purchased five years ago to house the victims of Hurricane Katrina.

The article cites FEMA as saying that “wholesale buyers from the auction must sign contracts attesting that trailers will not be used, sold or advertised as housing, and that trailers will carry a sticker saying, ‘Not to be used for housing’.”

Think that’s likely to be enough?  Read More »

Posted in Health science / Tagged , , , , | Read 5 Responses

Industry to EPA, Congress: Restrain me before I falsely claim CBI again!

By / Published: March 2, 2010

Richard Denison, Ph.D., is a Senior Scientist.

Sara Goodman of Greenwire/E&E News had a great piece picked up by the New York Times yesterday about state governments pressing for meaningful TSCA reform.  I blogged earlier about the states’ reform principles, quoting Ted Sturdevant, Director of the Washington State Department of Ecology, urging that “[w]e need a federal law that prevents contamination from happening in the first place, and phases out the harmful chemicals that are already in widespread use.”

Goodman’s piece yesterday focused more on the need for fundamental reform of confidential business information (CBI) claim allowances under TSCA.  Recall that, under TSCA, state governments as well as the public are denied access to any CBI EPA receives.  Judging by their quotes in Goodman’s piece, they’re not happy about it:  Read More »

Posted in Health policy, Regulation / Tagged , | Comments are closed

EPA IG report: New Chemicals Program fails to assure protection

By / Published: February 20, 2010

Richard Denison, Ph.D., is a Senior Scientist.

In a post to this blog nearly a year ago, I noted that many voices in the chemical industry were claiming that EPA’s New Chemicals Program (NCP) was robust and served as an excellent model for TSCA reform.  My post took considerable issue with that point of view, noting the many structural constraints TSCA imposes on EPA in its effort to review new chemicals:

  • No data, no problem: No up-front testing requirement or minimum data set applies to new chemicals.
  • Guessing game: EPA is forced to heavily rely on limited models and methods to predict the toxicity or behavior of a new chemical.
  • Catch-22: While EPA can require testing of a new chemical on a case-by-case basis, it must first show the chemical may pose a risk – not an easy task without any data in the first place!
  • One bite at the apple: EPA typically gets only a single opportunity to review a new chemical.
  • Crystal-ball gazing: EPA has to try to anticipate a new chemical’s for-all-time future production and use.
  • Black box: New chemical reviews lack transparency.
  • Anti-precaution: In deciding whether to require testing or controls for a new chemical, EPA equates lack of evidence of harm with evidence of no harm.

Lately, I’ve been hearing chemical industry representatives trying to resuscitate the NCP-as-model-for-TSCA-reform mantra.  So it is especially timely that a new report from EPA’s Office of Inspector General (OIG) has just been released that again thoroughly dismantles that notion.  The new report’s critique of the NCP closely mirrors the appraisal I provided earlier.  And adding weight to its analysis is the fact that EPA’s senior management has fully concurred with the report’s conclusions and recommendations. Read More »

Posted in Health policy, Regulation / Tagged , , , | Read 2 Responses

Worse than we thought: Decades of out-of-control CBI claims under TSCA

By / Published: February 12, 2010

Richard Denison, Ph.D., is a Senior Scientist.

I recently obtained – not without some effort on both EPA’s and my part – a scanned copy of a 1992 report commissioned by EPA innocuously titled “Influence of CBI Requirements on TSCA Implementation,” authored by the now-defunct Hampshire Research Associates.  I subsequently found a copy in an old EPA docket, located here (6 MB PDF file).

This understated yet remarkable report is a veritable treasure trove of information that painstakingly documents the rampant rise in illegitimate confidential business information (CBI) claims made by the chemical industry in the first decade after passage of the Toxic Substances Control Act (TSCA) – and the very limited options available to EPA to stop such activity (despite recent admirable efforts on its part). Read More »

Posted in Health policy, Regulation / Tagged , , , | Read 2 Responses

Toxic Chemicals in Consumer Products: More than Just Consumer Exposure

By / Published: February 8, 2010

Cal Baier-Anderson, Ph.D., is a Health Scientist.

An article recently published in the journal Macromolecules reports on the development of a new process that the authors claim can prevent the migration of phthalates from PVC plastic.   This “breakthrough” will undoubtedly be used to argue that industry should be allowed to continue to use a retinue of toxic chemicals in the manufacture of PVC destined for use in a broad variety of applications.

Concern for consumer exposures is often the main argument made against the use of toxic chemicals in consumer applications.  With evidence of exposure to chemicals like phthalates in nearly everyone who has been tested, including pregnant women, this is understandable.

But even if the new claims are proven to be true, there are many other reasons we need to find safer substitutes for such chemicals: worker exposures, environmental releases and end-of-life recycling and disposal issues, to name a few.  The potential impacts from continued use of toxic chemicals must be examined across their entire lifecycle. Read More »

Posted in Emerging science, Health science / Tagged , , , | Read 2 Responses